These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19762256)

  • 1. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance.
    Azémar MD; Comperat E; Richard F; Cussenot O; Rouprêt M
    Urol Oncol; 2011; 29(2):130-6. PubMed ID: 19762256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary upper urinary tract tumors and subsequent location in the bladder].
    Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the bladder localization of urothelial transitional carcinoma a nosologic entity different from tumors appearing in the upper urinary tract?].
    Escudero Barrilero A; Fernández Fernández E; Fernández Fernández A; Rodríguez Luna JM; Platas Sancho A
    Arch Esp Urol; 1989; 42(1):33-8. PubMed ID: 2653237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
    Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
    BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM; Rouprêt M
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review of ureteral carcinoma as seen in mapping of the cystectomized bladder].
    Kim CG; Hamada H; Koh E; Saiki S; Kinouchi T; Kuroda M; Miki T; Kiyohara H; Usami M; Nakamura M
    Hinyokika Kiyo; 1987 May; 33(5):692-6. PubMed ID: 3310556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
    Moussa S; Yafi FA; El-Hakim A; Fahmy N; Aprikian A; Tanguay S; Anidjar M; Kassouf W
    Urol Int; 2010; 84(1):50-5. PubMed ID: 20173369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer.
    Canales BK; Anderson JK; Premoli J; Slaton JW
    J Urol; 2006 Jan; 175(1):74-7. PubMed ID: 16406874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
    Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
    J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.